Henry Schein, Inc. (NASDAQ:HSIC) Receives Consensus Rating of “Hold” from Analysts

Shares of Henry Schein, Inc. (NASDAQ:HSIC) have been assigned a consensus rating of “Hold” from the eleven ratings firms that are presently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, five have issued a hold rating and five have assigned a buy rating to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $81.09.

Several brokerages have recently commented on HSIC. SVB Leerink began coverage on shares of Henry Schein in a research note on Monday, February 26th. They set a “market perform” rating and a $78.00 price objective for the company. JPMorgan Chase & Co. lifted their price objective on Henry Schein from $82.00 to $88.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 6th. Piper Sandler upped their target price on Henry Schein from $78.00 to $86.00 and gave the company an “overweight” rating in a report on Monday, February 26th. TheStreet upgraded shares of Henry Schein from a “c+” rating to a “b-” rating in a report on Monday, February 26th. Finally, Leerink Partnrs reaffirmed a “market perform” rating on shares of Henry Schein in a research report on Monday, February 26th.

Henry Schein Price Performance

HSIC opened at $71.86 on Thursday. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.67 and a quick ratio of 1.00. The stock’s 50 day simple moving average is $74.99 and its 200 day simple moving average is $72.60. The firm has a market cap of $9.23 billion, a price-to-earnings ratio of 22.81, a PEG ratio of 1.80 and a beta of 0.87. Henry Schein has a 1 year low of $60.01 and a 1 year high of $85.75.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, February 27th. The company reported $0.66 earnings per share for the quarter, missing analysts’ consensus estimates of $0.70 by ($0.04). Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The company had revenue of $3.02 billion for the quarter, compared to analysts’ expectations of $3 billion. During the same period last year, the company posted $1.21 EPS. The business’s revenue for the quarter was down 10.5% compared to the same quarter last year. As a group, analysts predict that Henry Schein will post 5.07 earnings per share for the current year.

Insider Transactions at Henry Schein

In related news, CEO Bradford C. Connett sold 6,430 shares of the firm’s stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the sale, the chief executive officer now owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of the company’s stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total transaction of $477,620.40. Following the transaction, the chief executive officer now owns 73,108 shares in the company, valued at approximately $5,430,462.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Vice Chairman James P. Breslawski sold 2,907 shares of Henry Schein stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $74.37, for a total transaction of $216,193.59. Following the completion of the sale, the insider now owns 209,562 shares of the company’s stock, valued at $15,585,125.94. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

Institutional Trading of Henry Schein

A number of hedge funds have recently bought and sold shares of the company. Baystate Wealth Management LLC lifted its stake in shares of Henry Schein by 2,500.0% during the 3rd quarter. Baystate Wealth Management LLC now owns 520 shares of the company’s stock valued at $39,000 after buying an additional 500 shares in the last quarter. McGlone Suttner Wealth Management Inc. purchased a new position in Henry Schein in the 4th quarter worth approximately $39,000. Neo Ivy Capital Management purchased a new position in Henry Schein in the 3rd quarter worth approximately $46,000. Covestor Ltd boosted its stake in Henry Schein by 88.4% in the 1st quarter. Covestor Ltd now owns 861 shares of the company’s stock worth $75,000 after purchasing an additional 404 shares during the period. Finally, Harbour Investments Inc. grew its holdings in Henry Schein by 27,725.0% during the 4th quarter. Harbour Investments Inc. now owns 1,113 shares of the company’s stock valued at $84,000 after buying an additional 1,109 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.